Telesis Bio, Inc.

TBIO · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$48-$48-$39-$18
Dep. & Amort.$4$3$2$1
Deferred Tax$0$0$2$0
Stock-Based Comp.$4$4$1$0
Change in WC-$8$2-$3-$0
Other Non-Cash$13$1$0$1
Operating Cash Flow-$35-$39-$37-$15
Investing Activities
PP&E Inv.-$2-$4-$2-$0
Net Acquisitions$0-$1-$13$0
Inv. Purchases-$34-$77$0$0
Inv. Sales/Matur.$30$64$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$6-$18-$15-$0
Financing Activities
Debt Repay.-$15$5$10-$0
Stock Issued$27$1$112$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$27-$1-$1$0
Financing Cash Flow$12$5$121-$0
Forex Effect-$0$0$0$0
Net Chg. in Cash-$29-$52$69-$16
Supplemental Information
Beg. Cash$31$83$13$29
End Cash$2$31$83$13
Free Cash Flow-$37-$43-$39-$16